Host genetic factors in predicting response status in chronic hepatitis B patients discontinuing nucleos(t)ide analogs

Background/Aims: The optimal duration of nucleos(t)ide analogs (NAs) therapy in chronic hepatitis B (CHB) patients remains unsatisfactory. Previous studies have confirmed the important role of host genetic factors in determining the outcome of HBV infection. This study tries to determine the role of...

Full description

Bibliographic Details
Main Authors: Tao Li, Feng Liu, Lixin Zhang, Qian Ye, Xiaoping Fan, Yan Xue, Lei Wang
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2018-01-01
Series:The Saudi Journal of Gastroenterology
Subjects:
Online Access:http://www.saudijgastro.com/article.asp?issn=1319-3767;year=2018;volume=24;issue=1;spage=30;epage=36;aulast=Li